Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:12 UTC |
---|
HMDB ID | HMDB0000819 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Normetanephrine |
---|
Description | Normetanephrine, also known as normetadrenaline or N111, belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. Normetanephrine is a solid that is soluble in water. Normetanephrine is a metabolite of norepinephrine created by action of catechol-O-methyl transferase on norepinephrine. Within humans, normetanephrine participates in a number of enzymatic reactions. In particular, normetanephrine can be converted into 3-methoxy-4-hydroxyphenylglycolaldehyde through its interaction with the enzyme amine oxidase [flavin-containing] A. It is also involved in the metabolic disorder called transient tyrosinemia of the newborn. This compound is excreted in the urine and is found in certain tissues. It is a marker for catecholamine-secreting tumors such as pheochromocytoma (PMID: 30538672 ). |
---|
Structure | InChI=1S/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3 |
---|
Synonyms | Value | Source |
---|
(+/-)-normetanephrine | HMDB | (+/-)-alpha-(aminomethyl)-4-hydroxy-3-methoxy-benzenemethanol | HMDB | 3-Methoxy-noradrenaline | HMDB | 3-O-Methyl-noradrenaline | HMDB | 4-(2-Amino-1-hydroxyethyl)-2-methoxyphenol | HMDB | alpha-(Aminomethyl)-4-hydroxy-3-methoxy-benzenemethanol | HMDB | DL-N-Normetanephrine | HMDB | DL-Normetanephrine | HMDB | L-Normetanephrine | HMDB | m-O-Methylnorepinephrine | HMDB | N111 | HMDB | Normetadrenaline | HMDB | O-Methylnoradrenaline | HMDB | 3 Methoxynoradrenaline | HMDB | 3-Methoxynoradrenaline | HMDB |
|
---|
Chemical Formula | C9H13NO3 |
---|
Average Molecular Weight | 183.2044 |
---|
Monoisotopic Molecular Weight | 183.089543287 |
---|
IUPAC Name | 4-(2-amino-1-hydroxyethyl)-2-methoxyphenol |
---|
Traditional Name | (+/-)-normetanephrine |
---|
CAS Registry Number | 97-31-4 |
---|
SMILES | COC1=CC(=CC=C1O)C(O)CN |
---|
InChI Identifier | InChI=1S/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3 |
---|
InChI Key | YNYAYWLBAHXHLL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenols |
---|
Sub Class | Methoxyphenols |
---|
Direct Parent | Methoxyphenols |
---|
Alternative Parents | |
---|
Substituents | - Methoxyphenol
- Phenoxy compound
- Anisole
- Phenol ether
- Methoxybenzene
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Monocyclic benzene moiety
- Secondary alcohol
- 1,2-aminoalcohol
- Ether
- Primary amine
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Alcohol
- Aromatic alcohol
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 204 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -1.05 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Normetanephrine,1TMS,isomer #1 | COC1=CC(C(O)CN)=CC=C1O[Si](C)(C)C | 1829.6 | Semi standard non polar | 33892256 | Normetanephrine,1TMS,isomer #2 | COC1=CC(C(CN)O[Si](C)(C)C)=CC=C1O | 1749.6 | Semi standard non polar | 33892256 | Normetanephrine,1TMS,isomer #3 | COC1=CC(C(O)CN[Si](C)(C)C)=CC=C1O | 1913.0 | Semi standard non polar | 33892256 | Normetanephrine,2TMS,isomer #1 | COC1=CC(C(CN)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 1769.9 | Semi standard non polar | 33892256 | Normetanephrine,2TMS,isomer #2 | COC1=CC(C(O)CN[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 1889.9 | Semi standard non polar | 33892256 | Normetanephrine,2TMS,isomer #3 | COC1=CC(C(CN[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O | 1818.7 | Semi standard non polar | 33892256 | Normetanephrine,2TMS,isomer #4 | COC1=CC(C(O)CN([Si](C)(C)C)[Si](C)(C)C)=CC=C1O | 2055.9 | Semi standard non polar | 33892256 | Normetanephrine,3TMS,isomer #1 | COC1=CC(C(CN[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 1806.7 | Semi standard non polar | 33892256 | Normetanephrine,3TMS,isomer #1 | COC1=CC(C(CN[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 1928.6 | Standard non polar | 33892256 | Normetanephrine,3TMS,isomer #1 | COC1=CC(C(CN[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2102.6 | Standard polar | 33892256 | Normetanephrine,3TMS,isomer #2 | COC1=CC(C(O)CN([Si](C)(C)C)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2060.8 | Semi standard non polar | 33892256 | Normetanephrine,3TMS,isomer #2 | COC1=CC(C(O)CN([Si](C)(C)C)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2092.4 | Standard non polar | 33892256 | Normetanephrine,3TMS,isomer #2 | COC1=CC(C(O)CN([Si](C)(C)C)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2295.0 | Standard polar | 33892256 | Normetanephrine,3TMS,isomer #3 | COC1=CC(C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O | 2045.1 | Semi standard non polar | 33892256 | Normetanephrine,3TMS,isomer #3 | COC1=CC(C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O | 2148.0 | Standard non polar | 33892256 | Normetanephrine,3TMS,isomer #3 | COC1=CC(C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O | 2262.5 | Standard polar | 33892256 | Normetanephrine,4TMS,isomer #1 | COC1=CC(C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2094.8 | Semi standard non polar | 33892256 | Normetanephrine,4TMS,isomer #1 | COC1=CC(C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2068.0 | Standard non polar | 33892256 | Normetanephrine,4TMS,isomer #1 | COC1=CC(C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2074.0 | Standard polar | 33892256 | Normetanephrine,1TBDMS,isomer #1 | COC1=CC(C(O)CN)=CC=C1O[Si](C)(C)C(C)(C)C | 2061.9 | Semi standard non polar | 33892256 | Normetanephrine,1TBDMS,isomer #2 | COC1=CC(C(CN)O[Si](C)(C)C(C)(C)C)=CC=C1O | 2021.1 | Semi standard non polar | 33892256 | Normetanephrine,1TBDMS,isomer #3 | COC1=CC(C(O)CN[Si](C)(C)C(C)(C)C)=CC=C1O | 2164.5 | Semi standard non polar | 33892256 | Normetanephrine,2TBDMS,isomer #1 | COC1=CC(C(CN)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2264.0 | Semi standard non polar | 33892256 | Normetanephrine,2TBDMS,isomer #2 | COC1=CC(C(O)CN[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2376.4 | Semi standard non polar | 33892256 | Normetanephrine,2TBDMS,isomer #3 | COC1=CC(C(CN[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O | 2316.7 | Semi standard non polar | 33892256 | Normetanephrine,2TBDMS,isomer #4 | COC1=CC(C(O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C1O | 2500.1 | Semi standard non polar | 33892256 | Normetanephrine,3TBDMS,isomer #1 | COC1=CC(C(CN[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2527.4 | Semi standard non polar | 33892256 | Normetanephrine,3TBDMS,isomer #1 | COC1=CC(C(CN[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2550.6 | Standard non polar | 33892256 | Normetanephrine,3TBDMS,isomer #1 | COC1=CC(C(CN[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2482.3 | Standard polar | 33892256 | Normetanephrine,3TBDMS,isomer #2 | COC1=CC(C(O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2763.3 | Semi standard non polar | 33892256 | Normetanephrine,3TBDMS,isomer #2 | COC1=CC(C(O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2712.9 | Standard non polar | 33892256 | Normetanephrine,3TBDMS,isomer #2 | COC1=CC(C(O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2587.1 | Standard polar | 33892256 | Normetanephrine,3TBDMS,isomer #3 | COC1=CC(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O | 2702.8 | Semi standard non polar | 33892256 | Normetanephrine,3TBDMS,isomer #3 | COC1=CC(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O | 2736.7 | Standard non polar | 33892256 | Normetanephrine,3TBDMS,isomer #3 | COC1=CC(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O | 2550.9 | Standard polar | 33892256 | Normetanephrine,4TBDMS,isomer #1 | COC1=CC(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2941.6 | Semi standard non polar | 33892256 | Normetanephrine,4TBDMS,isomer #1 | COC1=CC(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2813.2 | Standard non polar | 33892256 | Normetanephrine,4TBDMS,isomer #1 | COC1=CC(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2510.3 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Normetanephrine GC-MS (4 TMS) | splash10-00di-2920000000-906a2c3ec3c929834c7b | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Normetanephrine GC-MS (Non-derivatized) | splash10-00di-2920000000-906a2c3ec3c929834c7b | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9600000000-df1660d54bc99d55b9bb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (2 TMS) - 70eV, Positive | splash10-00di-1900000000-f8b939907bf23331b83f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Normetanephrine GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-014i-0900000000-cb28fbf84eae6ad4628e | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-05e9-4900000000-65aa73bd819270237f34 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-004i-9200000000-de463de74a0d6a9bfdb1 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 40V, Positive-QTOF | splash10-004i-9200000000-efafce5afe4a7c15067b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 20V, Positive-QTOF | splash10-05ai-1900000000-93cae41cf9bbc8fb06fa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 10V, Positive-QTOF | splash10-014i-0900000000-4f226dd2298708c36b4d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 35V, Positive-QTOF | splash10-0h3s-5900000000-7420f0a05449387c69eb | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 10V, Positive-QTOF | splash10-014i-0900000000-fa66b6a75bb70a6e11cb | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 20V, Positive-QTOF | splash10-05ai-1900000000-7eaa1d030beaeae5118f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 35V, Negative-QTOF | splash10-0002-0900000000-c2a7cb2d1889ec69b26a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 40V, Positive-QTOF | splash10-004i-9300000000-98a0488cc1211d99fa57 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 10V, Negative-QTOF | splash10-0002-0900000000-9997c3e9112e4558aa63 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 20V, Negative-QTOF | splash10-006t-0900000000-bd5a22c7a438d15be4bc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 40V, Negative-QTOF | splash10-00dl-7900000000-863bf83793f05b65058a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 35V, Negative-QTOF | splash10-0002-0900000000-2a2538378e0bbcaed15f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Normetanephrine 35V, Negative-QTOF | splash10-0002-0900000000-4414d75b49a2cc82bdb6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 10V, Positive-QTOF | splash10-0159-0900000000-b19888f59670d542cc35 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 20V, Positive-QTOF | splash10-014j-0900000000-26872ea42b5102a407ff | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 40V, Positive-QTOF | splash10-0fdt-4900000000-2416e3adcd40b107923d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 10V, Negative-QTOF | splash10-001i-0900000000-f95a5de2b99b6807a9ae | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 20V, Negative-QTOF | splash10-0gx0-0900000000-e2ba422610b39356fe57 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 40V, Negative-QTOF | splash10-0ab9-3900000000-f9f0aaa8b3c0fcfee29a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 10V, Positive-QTOF | splash10-001i-0900000000-ec4dd90d9b4a388fca9c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 20V, Positive-QTOF | splash10-001i-2900000000-f0ee1c53996f65eaa5cc | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Normetanephrine 40V, Positive-QTOF | splash10-0zgi-9300000000-91b1e27073d44d8f5025 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Urine
|
---|
Tissue Locations | - Adrenal Gland
- Adrenal Medulla
- Brain
- Platelet
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.00035 +/- 0.00016 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00022 +/- 0.00052 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00045 +/- 0.00120 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0052 uM | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.85 +/- 3.17 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 0.00085 +/- 0.00317 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | <0.322 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0340-0.182 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.00100-0.0180 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.0920-0.824 umol/mmol creatinine | Children (1-13 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.062 +/- 0.037 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details |
|
---|
Abnormal Concentrations |
---|
| |
Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000846 +/- 0.00037 uM | Not Specified | Not Specified | Alcohol abstinence | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000185 +/- 0.00004424 uM | Not Specified | Not Specified | pheochromocytoma | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00004533 +/- 0.00001256 uM | Not Specified | Not Specified | Primary hypertension | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Unclassified IBD | | details | Urine | Detected and Quantified | 0.392-0.666 umol/mmol creatinine | Adult (>18 years old) | Male | Brunner Syndrome | | details | Urine | Detected and Quantified | 0.0520-0.0780 umol/mmol creatinine | Adult (>18 years old) | Male | Brunner Syndrome | | details | Urine | Detected and Quantified | 0.016 umol/mmol creatinine | Children (1-13 years old) | Female | Aromatic L-amino acid decarboxylase deficiency | | details | Urine | Detected and Quantified | 0.055 umol/mmol creatinine | Infant (0-1 year old) | Female | Aromatic L-amino acid decarboxylase deficiency | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Pheochromocytoma |
---|
- Foti A, Adachi M, DeQuattro V: The relationships of free to conjugated normetanephrine in plasma and spinal fluid of hypertensive patients. J Clin Endocrinol Metab. 1982 Jul;55(1):81-5. [PubMed:7076810 ]
| Essential hypertension |
---|
- Foti A, Adachi M, DeQuattro V: The relationships of free to conjugated normetanephrine in plasma and spinal fluid of hypertensive patients. J Clin Endocrinol Metab. 1982 Jul;55(1):81-5. [PubMed:7076810 ]
| Crohn's disease |
---|
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Ulcerative colitis |
---|
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Aromatic L-amino acid decarboxylase deficiency |
---|
- Abeling NG, van Gennip AH, Barth PG, van Cruchten A, Westra M, Wijburg FA: Aromatic L-amino acid decarboxylase deficiency: a new case with a mild clinical presentation and unexpected laboratory findings. J Inherit Metab Dis. 1998 Jun;21(3):240-2. [PubMed:9686366 ]
| Brunner Syndrome |
---|
- Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993 Jun;52(6):1032-9. [PubMed:8503438 ]
|
|
---|
Associated OMIM IDs | - 171300 (Pheochromocytoma)
- 266600 (Crohn's disease)
- 608643 (Aromatic L-amino acid decarboxylase deficiency)
- 300615 (Brunner Syndrome)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022265 |
---|
KNApSAcK ID | C00037562 |
---|
Chemspider ID | 1200 |
---|
KEGG Compound ID | C05589 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | 46080 |
---|
Wikipedia Link | Normetanephrine |
---|
METLIN ID | 66 |
---|
PubChem Compound | 1237 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 144308 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | NORMETE_L |
---|
MarkerDB ID | MDB00000260 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Sejbal, Jan; Krecek, Vaclav. Method of preparing normetanephrine. Czech. (1992), 4 pp. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Goldstein DS, Eisenhofer G, Kopin IJ: Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003 Jun;305(3):800-11. Epub 2003 Mar 20. [PubMed:12649306 ]
- Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW: Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab. 1998 Jun;83(6):2175-85. [PubMed:9626157 ]
- Wester P, Bergstrom U, Eriksson A, Gezelius C, Hardy J, Winblad B: Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem. 1990 Apr;54(4):1148-56. [PubMed:1968956 ]
- Schmidt J, Mohr VD, Metzger P, Zirngibl H: Posttraumatic hypertension secondary to adrenal hemorrhage mimicking pheochromocytoma: case report. J Trauma. 1999 May;46(5):973-5. [PubMed:10338428 ]
- Eisenhofer G, Huysmans F, Pacak K, Walther MM, Sweep FC, Lenders JW: Plasma metanephrines in renal failure. Kidney Int. 2005 Feb;67(2):668-77. [PubMed:15673315 ]
- Orsulak PJ, Kizuka P, Grab E, Schildkraut JJ: Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection. Clin Chem. 1983 Feb;29(2):305-9. [PubMed:6821934 ]
- Linos DA: Management approaches to adrenal incidentalomas (adrenalomas). A view from Athens, Greece. Endocrinol Metab Clin North Am. 2000 Mar;29(1):141-57. [PubMed:10732269 ]
- Oishi S, Sasaki M, Sato T, Isogai M: Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature. Jpn J Clin Oncol. 1995 Aug;25(4):153-8. [PubMed:7666591 ]
- Filaire E, Legrand B, Bret K, Sagnol M, Cottet-Emard JM, Pequignot JM: Psychobiologic responses to 4 days of increased training and recovery in cyclists. Int J Sports Med. 2002 Nov;23(8):588-94. [PubMed:12439775 ]
- Filaire E, Legrand B, Lac G, Pequignot JM: Training of elite cyclists: effects on mood state and selected hormonal responses. J Sports Sci. 2004 Nov-Dec;22(11-12):1025-33. [PubMed:15801496 ]
- Higa S, Suzuki T, Sakoda S, Kishimoto S, Takaba Y, Nakajima A, Markey SP: Disturbed function of the pineal gland in familial amyloid polyneuropathy. J Neural Transm. 1987;69(1-2):97-103. [PubMed:3035087 ]
- Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K: Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab. 2005 Apr;90(4):2068-75. Epub 2005 Jan 11. [PubMed:15644397 ]
- Pacak K, Ilias I, Adams KT, Eisenhofer G: Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med. 2005 Jan;257(1):60-8. [PubMed:15606377 ]
- Guller U, Turek J, Eubanks S, Delong ER, Oertli D, Feldman JM: Detecting pheochromocytoma: defining the most sensitive test. Ann Surg. 2006 Jan;243(1):102-7. [PubMed:16371743 ]
- Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM, Brouwers FM, Pacak K: Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem. 2005 Apr;51(4):735-44. Epub 2005 Feb 17. [PubMed:15718487 ]
- Alrezk R, Suarez A, Tena I, Pacak K: Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging. Front Endocrinol (Lausanne). 2018 Nov 27;9:515. doi: 10.3389/fendo.2018.00515. eCollection 2018. [PubMed:30538672 ]
|
---|